Last update 02 May 2024
OnKure, Inc.

OnKure, Inc.

Holding Company|
2011|
Colorado, United States
|
< 10
|

Overview

Tags

Neoplasms
Skin and Musculoskeletal Diseases
Other Diseases
Small molecule drug
Gene therapy
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms15
Top 5 Drug TypeCount
Small molecule drug13
Chemical drugs1
Gene therapy1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Jun 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
12
2
Preclinical
Phase 2 Clinical
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Bocodepsin
( HDACs )
NRAS Mutant Melanoma
More
Phase 2
OKI-1546
( CDK12 )
Neoplasms
More
Preclinical
OKI-219
( PI3Kα H1047R )
Neoplasms
More
Preclinical
OKI-DISC-3
( Phosphotransferases )
Neoplasms
More
Discovery
OKI-DISC-2
( RTK )
Neoplasms
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free